Press Release: Dentons advises cannabis firm’s trans-Atlantic acquisition, plant helped by “Plant”, we could say.

London—Dentons has advised Canada-based Canopy Growth Corporation on its acquisition of skincare and well-being business This Works for £43 million.

Canopy Growth is a world leading diversified cannabis, hemp and cannabis device company. This acquisition is a key aspect of a multi-faceted hemp and CBD strategy as Canopy Growth continues to build upon its vertically-integrated production and marketing platform, that currently includes thousands of acres of hemp production across several continents, hundreds of millions of dollars of capital investment into hemp-derived CBD production and processing, rapid expansion across the European Union and other key regions, and the introduction of new CBD-infused products and brands to the global beauty, wellness, and sleep solution space.

Founded in 2004 and based in London, England, This Works offers a variety of natural skincare and sleep solution products, including the deep sleep pillow spray which has sold over 4.2 million units across Europe, the UK, China and the US.

Francesca Bettermann, counsel in Dentons’ UK Corporate team, said, “We are delighted to have advised Canopy Growth, one of the biggest cannabis companies in Canada, on this transaction. Its acquisition of This Works will connect a leading UK-based wellness brand with a world-leading diversified cannabis and hemp company.”

Alongside Francesca, the cross border Dentons team advising on the deal included Corporate partner Nicholas Plant and Tax partner James Meakin in London, Corporate associate David Rizzuto in Milton Keynes, and Corporate counsel Jason Trainor in Ottawa.

https://www.dentons.com/en/whats-different-about-dentons/connecting-you-to-talented-lawyers-around-the-globe/news/2019/june/dentons-advises-cannabis-company-canopy-growth